Mycos-P Oral Suspension
By Mycos-P
Rx
105ml Oral Suspension in a Bottle

Composition
Posaconazole(40mg/ml)

Manufacturer - Lincoln Pharmaceuticals Ltd
LINCOLN HOUSE, B/h. Satyam Complex, Science City Road, Sola, Ahmedabad – 380 062., Gujarat, India,

Expires on or after
October, 2025

liver
Mycos-P Oral Suspension is generally considered safe for use in individuals with liver disease. The available data indicates that adjusting the dosage of Mycos-P Oral Suspension may not be necessary for patients with liver issues. It is advisable to seek guidance from your healthcare provider before using this medication, especially if you have liver concerns.

kidney
Caution should be observed when using Mycos-P Oral Suspension in patients with kidney disease. Dose adjustment may be necessary, and regular monitoring of kidney function tests is recommended. This medication is not suitable for individuals with moderate to severe kidney disease.

alcohol
When taking Mycos-P Oral Suspension, it is uncertain if consuming alcohol is safe. It is advisable to seek advice from your doctor before combining alcohol with this medication.

driving
When using Mycos-P Oral Suspension, be cautious when driving as it may cause dizziness, drowsiness, or blurred vision, affecting your ability to drive safely.

pregnancy
Mycos-P Oral Suspension may not be safe during pregnancy. Limited human studies, along with animal studies, have shown potential harm to the baby. Your doctor will consider the risks and benefits before prescribing. Please consult your doctor before using Mycos-P Oral Suspension.

breastfeeding
Mycos-P Oral Suspension is likely unsafe for breastfeeding. Limited data shows it may pass into breastmilk, potentially harming the baby.
Habit Forming | No |
Chemical Class | Azoles {Triazoles} |
Therapeutic Class | ANTI INFECTIVES |
Action Class | Fungal ergosterol synthesis inhibitor |
₹20990
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025